false 0001308547 0001308547 2024-08-19 2024-08-19

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

August 19, 2024

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

Class A common stock, $0.001 par value   DLB   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Section 8 – Other Events

 

Item 8.01

Other Events.

On August 19, 2024, Dolby Laboratories, Inc., a Delaware corporation, completed its previously announced acquisition of GE Licensing (as defined below) for an aggregate cash purchase price of $429,000,000, subject to certain purchase price adjustments. The acquisition was effected through the purchase of all the issued and outstanding equity interests of GE Intellectual Property Licensing, LLC, a Delaware limited liability company, and GE Technology Development, Inc., a Delaware corporation, which, collectively with each of their subsidiaries, comprised General Electric Company’s (operating as GE Aerospace) intellectual property licensing business primarily targeting the consumer digital media and electronics sectors (“GE Licensing”). The transaction was funded using cash on hand.

Section 9 - Financial Statements and Exhibits

Item 9.01 – Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

   

Description

104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOLBY LABORATORIES, INC.
By:  

/s/ ANDY SHERMAN

  Andy Sherman
  Executive Vice President, General Counsel, and Corporate Secretary

Date: August 19, 2024

v3.24.2.u1
Document and Entity Information
Aug. 19, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001308547
Document Type 8-K
Document Period End Date Aug. 19, 2024
Entity Registrant Name DOLBY LABORATORIES, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-32431
Entity Tax Identification Number 90-0199783
Entity Address, Address Line One 1275 Market Street
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94103-1410
City Area Code (415)
Local Phone Number 558-0200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Class A common stock, $0.001 par value
Trading Symbol DLB
Security Exchange Name NYSE
Entity Emerging Growth Company false
Dolby Laboratories (NYSE:DLB)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024 Haga Click aquí para más Gráficas Dolby Laboratories.
Dolby Laboratories (NYSE:DLB)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024 Haga Click aquí para más Gráficas Dolby Laboratories.